INGN
Inogen, Inc.
Set alert
6.86 USD -0.40 -5.51%
6.69 Day range 7.30
5.09 52-week range 8.24
- YTD
- +2.08%
- 1 year
- -16.03%
- Open
- 7.30
- Prev close
- 7.26
- Mkt cap
- 182.05M
- Vol
- 201.19K
- Avg vol
- 307.21K
- EPS
- -0.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.69
- High
- 7.30
- Forward P/E
- -5.44
- Beta
- 1.04
- Short ratio
- 3.36
- Inst. own
- 89.67%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.45
- 200-d avg
- 9.07
- 1y target
- 10.00
Key statistics
- Market cap
- 200.79M
- Enterprise value
- 101.46M
- Trailing P/E
- 0.00
- Forward P/E
- -5.44
- PEG ratio
- 0.00
- Price / sales
- 0.61
- Price / book
- 1.08
- EPS (TTM)
- -2.25
- Beta
- 1.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -15.89%
- Revenue (TTM)
- 331.52M
- Revenue growth
- 5.80%
- Free cash flow
- 2.52M
- Total cash
- 120.66M
- Total debt
- 20.15M
- Return on equity
- -25.33%
- Shares outstanding
- 23.82M
- Short % of float
- 3.35%
- 50-day average
- 9.45
- 200-day average
- 9.07
Analyst view
Consensus: hold
Hold
Price target (mean) 10.00
Ratings (0m) 4 1 buy · 2 hold · 1 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell1
Next earnings
Consensus EPS estimate -0.49.
Financials — quick view
INGN Revenue — quarterly 95.08M
INGN Net income — quarterly -3.85M
INGN EPS — quarterly -0.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.51 | -0.25 | +0.26 | +50.98% |
| Aug 6, 2024 | Jun 1, 2024 | -0.54 | -0.24 | +0.30 | +55.56% |
| May 7, 2024 | Mar 1, 2024 | -0.76 | -0.62 | +0.14 | +18.42% |
| Feb 27, 2024 | Dec 1, 2023 | -0.65 | -1.14 | -0.49 | -75.38% |
| Nov 7, 2023 | Sep 1, 2023 | -0.57 | -1.97 | -1.40 | -245.61% |
| Aug 7, 2023 | Jun 1, 2023 | -0.64 | -0.42 | +0.22 | +34.38% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 8, 2024 | Needham | reit | — | Hold |
| Aug 7, 2024 | Needham | reit | — | Hold |
| May 8, 2024 | Stifel | main | Hold | Hold |
| May 8, 2024 | Needham | reit | — | Hold |
| Apr 9, 2024 | Needham | reit | — | Hold |
| Feb 15, 2024 | William Blair | up | Market Perform | Outperform |
About Inogen, Inc.
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- inogen.com
News
- Inogen: Cheap Enough To Take A Chance On
- Inogen (NASDAQ:INGN) Share Price Breaks Above Fifty Day Moving Average – Should You Sell?
- Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026
- Full Transcript: Inogen Q2 2026 Earnings Call
- Inogen (NASDAQ:INGN) Stock Price Breaks Above Fifty Day Moving Average – What’s Next?
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Inogen Agrees To Divest Its U.S. Oxygen Rental Operations To Rotech Healthcare For $25M
- Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
- Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
- Top 3 Health Care Stocks That Could Blast Off This Month
Your note
Sign in to keep a note on INGN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOEHNLEIN GLENN S | Director | Stock Award(Grant) | Jun 4, 2024 | 46,273 |
| GLEZER STANISLAV | Officer | Conversion of Exercise of derivative security | Apr 30, 2024 | 32,049 |
| KING KEVIN M | Director | Stock Award(Grant) | Jun 4, 2024 | 46,273 |
| LADONE MARY KAY | Director | Stock Award(Grant) | Jun 4, 2024 | 46,273 |
| MORA ELIZABETH A | Director | Stock Award(Grant) | Jun 4, 2024 | 48,568 |
| RAMADE GREGOIRE | Officer | Conversion of Exercise of derivative security | Nov 28, 2024 | 18,623 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Camber Capital Management LP | 8.40% | 2,000,000 | 16.86M | Sep 29, 2024 |
| Blackrock Inc. | 7.30% | 1,738,651 | 14.66M | Sep 29, 2024 |
| Brown Capital Management, LLC | 6.54% | 1,558,458 | 13.14M | Sep 29, 2024 |
| Vanguard Group Inc | 6.29% | 1,498,656 | 12.63M | Sep 29, 2024 |
| Divisadero Street Capital Management, LP | 4.44% | 1,056,403 | 8.91M | Sep 29, 2024 |
| JP Morgan Chase & Company | 3.76% | 896,106 | 7.55M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.08% | 733,584 | 6.18M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.62% | 624,722 | 5.27M | Oct 30, 2024 |
| Columbia Fds Ser Tr I-Columbia Small Cap Value Fd I | 2.08% | 496,308 | 4.18M | Jul 30, 2024 |
| Bridgeway Funds Inc-Small Cap Value Fund | 1.81% | 430,179 | 3.63M | Sep 29, 2024 |
| Brown Capital Management Small Company Fund | 1.74% | 415,484 | 3.50M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.49% | 354,264 | 2.99M | Sep 29, 2024 |